知识产权

最新

1 至 10 of 576
  • Amsterdam to become new home of the EMA following tied EU vote

    文章

    提交: 22 November 2017

    The European Medicines Agency (EMA) is to relocate from London to Amsterdam following the UK's departure from the EU.

  • Implementing the new ABHI Code of Business Practice - update

    文章

    提交: 13 November 2017

    The ABHI has corrected a “typo” in the new ABHI Code which is relevant to the bulk of the new ABHI Code which will enter into force on 01 January 2018.

  • Implementing the new ABHI Code of Business Practice and Disclosure Guidelines published by MedTech Europe 受限访问

    文章

    最后审查: 10 November 2017 / 提交: 27 February 2017

    Following the adoption by MedTech Europe of a revised version of the MedTech Europe Code in late 2015, the ABHI has begun to implement it through the ABHI Code from 01 January 2017.

  • Voorkom veel gemaakte fouten in uw merkenportfolio 受限访问

    研讨会

    提交: 09 November 2017

    ​De merken van uw bedrijf zijn waardevolle assets. Het is dan ook opvallend dat de bescherming van uw merken in veel gevallen suboptimaal is. Paul Tjiam, hoofd van de afdeling soft IP, heeft samen met zijn collega’s onderzoek verricht bij circa 30 merkenportfolio’s van internationale en nationale bedrijven. Ruim drie kwart van deze bedrijven had zijn merkenportfolio niet volledig op orde. Onvoldoende merkbescherming kan leiden tot misbruik en inbreuk door derden.

  • Case update: Generics (Mylan) v Yeda and Teva

    文章

    提交: 06 November 2017

    The doctrine of equivalents and Arrow declarations take their first spin in the Patent Court after recent (re)emergence.

  • Autumn Legal Business Update 2017 受限访问

    会议

    最后审查: 24 October 2017 / 提交: 22 September 2017

    Learn about a broad range of topical issues relevant to financial institutions, asset managers and investment funds, from lawyers across many disciplines.

  • Alternative Data 受限访问

    研讨会

    最后审查: 24 October 2017 / 提交: 11 October 2017

    This session addresses the key legal and compliance issues regarding the use of alternative data, including IP, data privacy, regulatory and criminal risks.

  • Unified Patent Court: The slightly surprising limits of its jurisdiction

    文章

    提交: 18 October 2017

    The jurisdiction of the Unified Patent Court, within its area of competence, is somewhat broader than might be expected. Complexity arises due to the manner in which amendment of the Brussels Regulation brings the Unified Patent Court into the wider European context and the interplay between the Brussels regulation with the Lugano agreement.

  • Is there a future for medical device SPCs? Past, present and future perspectives

    文章

    提交: 18 October 2017

    This article reviews UK and European cases on the ability of the SPC system to be applied to medical devices and considers the main issues faced by such applications. It also considers whether now might be the time to introduce a new system for "medical device SPCs".

1 至 10 of 576